Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Mycroft hits crowdfunding goal in hours, raises $400K for Mark II
Mycroft’s Mark II crowdfunding campaign raised eight times its goal — and the tech firm is still counting. The Kansas City-based startup set out to raise $50,000 on Kickstarter and garner support from early adopters for its voice assistant product Mark II — similar to Amazon’s Alexa, Apple’s Siri or Microsoft’s Cortana. Mycroft “blew through”…
Negro leagues’ only three women players inspire ‘Beauty of the Game’ by KC designer Cherry
Toni Stone, Connie Morgan and Mamie Johnson — the only three women to play in the Negro baseball leagues — remain an inspiration to female entrepreneurs in male-dominated industries some 50 years later, said Thalia Cherry. “It’s still important for us to carve out a great space for ourselves, a great niche, and do the…
Ranking: KC defies gender pay gap, again earns No. 2 for Women in Tech
Second only to Washington, D.C., in a new national ranking, Kansas City boasts a noteworthy statistic: Women in tech jobs are paid, on average, 2 percent more than their male counterparts. It’s the fourth consecutive year Kansas City has earned a No. 2 on the list of the Best Cities for Women in Tech. But…
Operation Breakthrough expansion helps give every child a chance, Mayor Sly James says
It’s the beginning of a new chapter for Operation Breakthrough, said Kansas City Mayor Sly James. The mayor joined a packed crowd of supporters on an icy Thursday morning to share the Kansas City-based organization’s formal announcement of its $17 million capital campaign and expansion project. The effort — dubbed “Big Dreams, Bright Futures” —…